The CPNP Foundation has announced the continued funding of 20 student registration/travel grants to CPNP 2017 to be held April 23-26 in Phoenix, Arizona. Each student recipient will receive a full student registration to the 2017 Annual Meeting ($175 value) and a $325 travel stipend. These grants are possible because of the generous support of CPNP members and the CPNP Past Presidents’ who have recently created the Destiny Fund within the Foundation specifically to support student registration/travel grants.
According to CPNP Immediate Past President Ray Love, the CPNP Past Presidents are so impressed with the 100+ students on-site at CPNP 2016 and the amazing growth in student membership, now over 700 student members strong. CPNP Past Presidents feel it is critical to support these individuals in pursuing careers in psychiatric pharmacy so that we can continue to grow our profession and continue our impact on the future of those living with mental illness.”
Applications are being accepted now through January 20, 2017. To be eligible, a student applicant must be a full-time pharmacy student in pursuit of her/his first professional pharmacy degree, and an active student member of CPNP in good standing. Students applying for a registration/travel grant must complete an online application and provide a current curriculum vitae; a personal essay of no more than 500 words describing the applicant’s interest in CPNP and psychiatric pharmacy, including objectives for attending the meeting; and one letter of recommendation from either a clinical pharmacy practitioner or faculty member.
Matthew Fuller, PharmD, BCPP, President of the CPNP Foundation, commented, “The CPNP Foundation Board of Directors is very grateful to the CPNP membership and to the CPNP Past Presidents for their generous support of these grants. The Foundation Board firmly believes that these grants are critically important to the continuing growth of our discipline and the continuing improvement in the evidence-based care that individuals with psychiatric and neurologic disorders receive."